Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
I was under the impression most large funds can’t invest in micro or nano caps. How many actually have the option to invest in us? I’m willing to be educated.
11,250,575
Where are you getting 90%? Elite doesn’t break down it’s financials per product. Obviously they’ve grown their revenues substantially since those two products but how can you prove it’s 90%?
Fairly certain this is incorrect. I DO remember Nasrat saying, and I’m paraphrasing, that he came from a billion dollar company (Actavis) and that he wouldn’t be happy / would consider it a failure if Elite never rises above a few million a year on his watch. Don’t think I’ve ever heard him say his expectation is billions in revenue from Elite.
I guess the question is can Cardinal, McKesson, _____, etc. bring us better results than Lannett?
Even if our new “split” with the next partner happens to be a little lower percentage, if the total “pie” is bigger to begin with, we’re still okay.
Yes successful companies matter to investors - the basis/foundation upon which successful, legitimate, and sustainable stock prices are born. Elite has gone from bleeding cash to profitable, albeit over many years. The stock price will eventually follow, period.
“If ya can’t take the heat, get out tha kitchen”
Correct, Nasrat is still Elite’s CEO from 7/29 through to today.
$ELTP$
Lannett’s Adderall market share is impressive, given that at least Teva, Mallinckrodt, Novartis and Takeda are massive, multi-billion-in-revenue companies.
Shortage for Teva means potentially more market share opportunity for Lannett/us. Good news.
Let’s go $ELTP$.
Wish we’d have another PR before then but probably nothing happening until later in the year, right?
So a targeted hire, possibly for that very reason? Interesting. More ANDA launches on deck, trials on deck, profitability increasing. Hmm
Uhhh. Real investors perusing here should take note that Elite took out a $12M bank loan to purchase their facility instead of continuing to lease it. Naturally when one takes out a loan, their indebtedness increases until said loan balance is reduced or eliminated.
Investors also understand that conditions change between two SEC filings nearly a year apart from each other. People can indeed read and compare entire filings the dates on said filings, not just cherry picked statements lacking nearly all context.
Not “just my opinion” either, but facts.
Hmm let’s put our thinking caps on for one moment.
$1 million dollar salary per year vs:
$75 million dollars w/ 300M shares @.25
$150 million dollars w/ 300M shares @.50
$225 million dollars w/ 300M shares @.75
$300 million dollars w/ 300M shares @1.00
Does it REALLY make sense that Nasrat would prefer the ELTP stock price to stay low given what he stands to gain if it rises in price? Cmon, man. Common sense.
The least believable thing in this post is that the shake machine wasn’t off or broken.
Buying the facility, Oxy ER ANDA back in play, Sabril generic approved…. Things looking up again!
$ELTP
Esophagus != tummy. Cmon doc, you should know that.
$ELTP
Doxycycline freaking wrecked me as a younger kid. I took it for acne and after a few days, it felt like it ate away the lining of my esophagus/upper GI tract. I had to stop taking it and got on Nexium for a couple weeks to get back to normal. It got to where I didn’t want to eat during the worst of it, swallowing even saliva alone felt like fire all the way down. It’s the only drug I’ve ever taken that gave me any kind of significant adverse effect.
I knew of one other friend who had the exact same reaction to it, maybe we’re outliers though.
Hopefully Elite can make a modest entrance into the market on this one and with a relatively quick launch.
I will post often about $ELTP but only in a negative fashion because I believe this will somehow help the $ELTP stock I claim to own rise in price. I’m not sure how this will help my $ELTP stock rise but I’ll keep trying it day after day, week after week, year after year. I will post about the $ELTP share price being low even though I know it trades on the OTC where the massive majority of institutional firms don’t and can’t invest in sub $5 stocks like $ELTP. I will focus on the share price and share price alone because I cannot refute the growing cash on hand, profits, or drug portfolio any longer.
“Who is the only person who gets more and more while our investment is worth less and less? Anyone can answer... if they are willing to be honest with themselves.”
Nasrat + the other company executives/BoD who get paid in shares. They also have the same common shares we do. The same share price affects us all.
If we’re being fully honest though then we also have to consider why anyone, Nasrat included, would stockpile something they expected to be worthless or of extremely low value forever.
Hint - they wouldn’t.
I will post often about $ELTP but only in a negative fashion because I believe this will somehow help my $ELTP stock rise in price. I’m not sure how this will help the $ELTP stock I claim to own rise but I’ll keep trying it week after week, year after year. I will post about the $ELTP share price being low even though I know it trades on the OTC where the massive majority of institutional firms don’t and can’t invest in sub $5 stocks like $ELTP.
I will post often about $ELTP but only in a negative fashion because I believe this will somehow help my $ELTP stock rise in price. I’m not sure how this will help my $ELTP stock rise but I’ll keep trying it week after week, year after year. I will post about the $ELTP share price being low even though I know it trades on the OTC where the massive majority of institutional firms don’t and can’t invest in sub $5 stocks like $ELTP.
I too spend years upon years discussing stocks like $ELTP that I have no interest in and where nothing will ever happen. It is well worth my unpaid time to stay on the $ELTP message board and to continue discussing $ELTP where nothing ever happens or will happen. $ELTP is just like all the other companies/stock where the market cap equals, or is close to, the annual revenues and counting zero of the other assets. This is quite the productive use of my time discussing $ELTP.
Guess the question wasn’t understood then. Obviously 100% of something is better than 50%, except of course it isn’t that simple of a dichotomy. Add an extra ~$25M to get that last 50% ownership currently, and that’s assuming Nasrat and Epic group act as a unit and that none of them have sold any shares in 10+ years.
I guess anything is possible but the theory that Nasrat and Epic just came in to play the LOOOOOONG game and purposefully slow bleed Elite for nearly a decade to then have to also pay $25 million dollars to take it private, then take it back public again doesn’t hold water for me. If the plan was to effectively kill off the public version of Elite the whole time, then why file any ANDAs at all? Why launch more drugs? Why work on various partnerships? Just claim “R&D” but have all the new formulations “fail” and let the cash burn bury them. That had already been happening for many years before Treppel showed up. Why would they want Elite to ever be profitable at all?
So let’s extend this theory out. How does Nasrat and/or the group of Epic investors make more money taking Elite private than having Elite remain a public company and having the ELTP stock price rise?
At current levels, if I’m doing my rough math right and assuming the share count for Nas + Epic group holds at ~522M, wouldn’t it cost somewhere around $25 million dollars for them to pay off the remaining shareholders (~500M remaining OS x .05) and take Elite private? And then what? Keep running the company for a few million in annual profits but deal with raw materials and other costs to sustain? Sell it off to someone else? So -$25M to then have to try and turn around and make that much more in an acquisition?
Seems like a pretty dumb way to make money when you can just keep plugging away with new ANDAs and the stock price should eventually rise. At .50 - $1 PPS, assuming ownership is what you claim, the Nasrat/Epic “group” would have over a quarter to over half a BILLION dollars for seemingly a lot less work.
Even going with that theory, $10M (one of the OG Mikah deals) isn’t shit compared to a hypothetical $150M to $300M+ if the stock price got up to $.50 - $1 per share. Yes, the price has languished and we can certainly talk about overpromising and underdelivering but that still doesn’t change what I said.
The incentive to drive the price higher is there for Nasrat and the potential payout is gargantuan.
Nasrat stands to gain way more money than literally any other shareholder by a big rise in the stock price.
This is a clear and incontrovertible fact.
It is in Nasrat’s best interest, and in the best interests of his fellow shareholders, that the price goes up. Whether he actually “cares” about us is kinda irrelevant. Does he care about money is the real question. Driving that stock price up is where that real money is for him, and for other shareholders.
You’d honestly prefer him to be LESS invested in this company? Makes literally zero sense if the goal is making money here. Zero. LOL
Easy money
$1 PPS would make the wait worth it. Would take .50 at this point just based on time spent. Hopefully that’s the minimum.
Elite reports material events when they occur. If no material event, usually = no news. Very simple.
Just facts.
I’m buying shares myself, GL.
n
I’m still buying more shares myself, GL.
Indeed, lots of accumulation. No brainer to snag up on sale prices just like one would at a grocery store. Now is precisely when you want to buy, not when the price is already jumping.
But LCI has its own shareholders to worry about and often times, doesn’t the acquirer sort of take a “hit” from their shareholders’ perspectives? Seems like in my experience, buyouts are usually much more positive for the acquired than acquirer.
Would also have to be pretty devious for Lannett to self-sabotage their own products. How much would they really be “saving” in that case?
Lastly, Nasrat still ultimately has the most to gain from a large rise in price, not keeping the price in the gutter trying to obtain a few thousand more shares.
Still loading up as well, GL.
I’m still buying too, GL.
I’m still loading as well, GL.
Sucks for private companies then, guess it’s impossible for them to be purchased.
Agreed, truth. Company would’ve been dead and gone long ago if not for Treppel first and Nasrat second.
Talking about actual failed management, CEO-to-PPS performance... check out the company and stock price performance under the Bernard Berk era circa 2007ish and prior, then get back to me.
Easy money for the patient.
Nice! Good DD. Perhaps Elite will benefit from the increases in the CNS sales.
Let it be known that there was a MATERIAL EVENT today and a quote from Nasrat himself.